Kelun

Kelun, officially known as Sichuan Kelun Pharmaceutical Co., Ltd., is a major pharmaceutical company based in China. Founded in 1996, Kelun has grown to become one of the largest pharmaceutical manufacturers in the country, specializing in a wide range of products. Its primary focus areas include intravenous solutions, anti-infectives, cardiovascular drugs, and gastrointestinal medications.

The company operates numerous production facilities across China and invests significantly in research and development. Kelun is known for its extensive product portfolio, which serves various therapeutic areas. They are a prominent supplier of intravenous fluids and ready-to-use preparations, playing a crucial role in healthcare supply chains.

Kelun also engages in the production of generic drugs and has been expanding its capabilities in biological and innovative drug development. The company is listed on the Shenzhen Stock Exchange and is recognized for its substantial market share in several key pharmaceutical segments within China. Its operations are characterized by a commitment to quality control and adherence to pharmaceutical manufacturing standards.